Eur Rev Med Pharmacol Sci 2020; 24 (14): 7568-7568

DOI: 10.26355/eurrev_202007_22232

Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7

J. Zhang, W.-H. Gong, Y. Li, H.-Y. Zhang, C.-X. Zhang

Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

 


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7, by J. Zhang, W.-H. Gong, Y. Li, H.-Y. Zhang, C.-X. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (15): 6548-6553–DOI: 10.26355/eurrev_201908_18540–PMID: 31378895” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7

Free PDF Download

To cite this article

J. Zhang, W.-H. Gong, Y. Li, H.-Y. Zhang, C.-X. Zhang
Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 14
Pages: 7568-7568
DOI: 10.26355/eurrev_202007_22232